Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
Medrxiv : the Preprint Server for Health Sciences|July 29, 2024
Mass drug administration to reduce malaria incidence in a low-to-moderate endemic setting: short-term impact results from a cluster randomised controlled trial in SenegalEl-Hadji Ba Konko Ciré, Michelle E Roh, Abdoulaye Diallo, et al.
Plos Medicine|October 5, 2018
Correction: Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trialTesfay Abreha, Jimee Hwang, Kamala Thriemer, et al.
Malaria Journal|June 6, 2026
Analysis of the effect of primaquine dose on efficacy, safety, and tolerability in patients with Plasmodium vivax malaria in Ethiopia: a systematic review and individual patient data meta-analysisTamiru Shibiru Degaga, Kamala Thriemer, Megha Rajasekhar, et al.
Plos Medicine|May 17, 2017
Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trialTesfay Abreha, Jimee Hwang, Kamala Thriemer, et al.
Lancet (London, England)|April 26, 2026
Safety and efficacy of the monoclonal antibody L9LS for malaria prevention in children exposed to perennial malaria transmission in Kenya: a randomised, double-blind, placebo-controlled, phase 2 trialLaura C Steinhardt, Titus K Kwambai, Martina Oneko, et al.
The Lancet. Infectious Diseases|September 25, 2023
Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysisMegha Rajasekhar, Julie A Simpson, Benedikt Ley, et al.
Nature Medicine|October 26, 2023
Evidence for a role of Anopheles stephensi in the spread of drug- and diagnosis-resistant malaria in AfricaTadele Emiru, Dejene Getachew, Maxwell Murphy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2019
Safety, Tolerability, and Immunogenicity of Plasmodium falciparum Sporozoite Vaccine Administered by Direct Venous Inoculation to Infants and Young Children: Findings From an Age De-escalation, Dose-Escalation, Double-blind, Randomized Controlled Study in Western KenyaLaura C Steinhardt, Thomas L Richie, Reuben Yego, et al.
Journal of Clinical Virology Plus|January 23, 2023
Comparison of one single-antigen assay and three multi-antigen SARS-CoV-2 IgG assays in NigeriaNnaemeka C Iriemenam, Fehintola A Ige, Stacie M Greby, et al.
Frontiers in Immunology|November 17, 2022
Increased levels of anti-PfCSP antibodies in post-pubertal females versus males immunized with PfSPZ Vaccine does not translate into increased protective efficacyNatasha Kc, L W Preston Church, Pouria Riyahi, et al.
Pageof 14